This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Gunnel Sundén: Innovator in Thrombin Inhibition
Introduction
Gunnel Sundén is a notable inventor based in Mölndal, Sweden. She has made significant contributions to the field of medicinal chemistry, particularly in the development of thrombin inhibitors. Her work is recognized for its potential impact on therapeutic applications.
Latest Patents
Gunnel Sundén holds a patent for "Thiochromane derivatives and their use as thrombin inhibitors." This innovation represents a step forward in the search for effective anticoagulant therapies. The patent highlights her expertise in creating compounds that can modulate blood coagulation processes.
Career Highlights
Gunnel Sundén is associated with AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca has allowed her to work on cutting-edge research and development projects. She has been instrumental in advancing the company's portfolio of innovative therapies.
Collaborations
Gunnel has collaborated with esteemed colleagues such as Tord Bertil Inghardt and Olle Karlsson. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Gunnel Sundén's contributions to the field of thrombin inhibition exemplify her dedication to innovation in medicinal chemistry. Her work continues to influence the development of new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile